urapidil has been researched along with Liver Dysfunction in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urapidil is a selective alpha 1-adrenoceptor antagonist with central antihypertensive action which is increasingly used in the treatment of hypertension." | 4.77 | Clinical pharmacokinetics of urapidil. ( Haerlin, R; Kirsten, R; Nelson, K; Steinijans, VW; Zech, K, 1988) |
| "Urapidil does not inhibit the exercise increase in heart rate." | 2.38 | Urapidil, a multiple-action alpha-blocking drug. ( Prichard, BN; Renondin, JC; Tomlinson, B, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prichard, BN | 1 |
| Tomlinson, B | 1 |
| Renondin, JC | 1 |
| Kirsten, R | 1 |
| Nelson, K | 1 |
| Steinijans, VW | 1 |
| Zech, K | 1 |
| Haerlin, R | 1 |
2 reviews available for urapidil and Liver Dysfunction
| Article | Year |
|---|---|
Urapidil, a multiple-action alpha-blocking drug.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Animals; Antihypertensive Agents; Biological | 1989 |
Clinical pharmacokinetics of urapidil.
Topics: Adult; Aged; Aged, 80 and over; Aging; Digoxin; Drug Interactions; Half-Life; Humans; Hypertension; | 1988 |